Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer

Eyad Elkord, Paul E. Williams, Howard Kynaston, Anthony W. Rowbottom

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Induction of CTL responses specific for prostate-specific antigen (PSA)-derived peptides in healthy individuals and patients with prostate cancer (PC) was investigated. Eight PSA-derived peptides that have the potential to bind HLA-A2 molecules were examined. Peripheral blood lymphocytes isolated from HLA-A2-positive volunteers were expanded using autologous mature, PSA-derived peptide-pulsed dendritic cells. The expansion of IFN-γ-secreting CD8+ T cells specific for three of the eight PSA-derived peptides (PSA-2108-117, PSA-4141-150 and PSA-6146-154) was detected in healthy individuals, but not in patients with PC. Using HLA-A2/peptide tetramers, the PSA-specific CD8+ T cells were detectable at low frequency both in healthy individuals and patients with PC. Using flow cytometric cytotoxicity assays, the expanded effectors from healthy individuals were able to kill the PSA-expressing epithelial cell line LNCaP and the peptide-pulsed T2 cells in a MHC class I-restricted manner without involving NK activity. However, such killing by effectors expanded from prostatectomized patients involved a complete or a significant NK activity. Specific recognition of PSA-derived peptides in healthy individuals may occur by an adaptive CTL immune response, while such recognition in PC patients may additionally or alternatively be mediated by an innate NK immune response. In conclusion, our work indicates that the PSA-specific CD8+ T cells exist in both healthy individuals and PC patients, but they have impaired function in patients as they failed to release IFN-γ and to kill targets without involving NK activity.

Original languageEnglish
Pages (from-to)1315-1325
Number of pages11
JournalInternational Immunology
Volume17
Issue number10
DOIs
Publication statusPublished - Oct 2005
Externally publishedYes

Fingerprint

Prostate-Specific Antigen
Prostatic Neoplasms
Tissue Donors
Peptides
HLA-A2 Antigen
T-Lymphocytes
Adaptive Immunity
Innate Immunity
Dendritic Cells
Volunteers
Epithelial Cells
Lymphocytes
Cell Line

Keywords

  • Cytotoxic T lymphocytes
  • Dendritic cells
  • NK activity
  • Prostate cancer
  • Prostate-specific antigen

ASJC Scopus subject areas

  • Immunology

Cite this

Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer. / Elkord, Eyad; Williams, Paul E.; Kynaston, Howard; Rowbottom, Anthony W.

In: International Immunology, Vol. 17, No. 10, 10.2005, p. 1315-1325.

Research output: Contribution to journalArticle

Elkord, Eyad ; Williams, Paul E. ; Kynaston, Howard ; Rowbottom, Anthony W. / Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer. In: International Immunology. 2005 ; Vol. 17, No. 10. pp. 1315-1325.
@article{10f2c6906956465ca61dbf139496a8e6,
title = "Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer",
abstract = "Induction of CTL responses specific for prostate-specific antigen (PSA)-derived peptides in healthy individuals and patients with prostate cancer (PC) was investigated. Eight PSA-derived peptides that have the potential to bind HLA-A2 molecules were examined. Peripheral blood lymphocytes isolated from HLA-A2-positive volunteers were expanded using autologous mature, PSA-derived peptide-pulsed dendritic cells. The expansion of IFN-γ-secreting CD8+ T cells specific for three of the eight PSA-derived peptides (PSA-2108-117, PSA-4141-150 and PSA-6146-154) was detected in healthy individuals, but not in patients with PC. Using HLA-A2/peptide tetramers, the PSA-specific CD8+ T cells were detectable at low frequency both in healthy individuals and patients with PC. Using flow cytometric cytotoxicity assays, the expanded effectors from healthy individuals were able to kill the PSA-expressing epithelial cell line LNCaP and the peptide-pulsed T2 cells in a MHC class I-restricted manner without involving NK activity. However, such killing by effectors expanded from prostatectomized patients involved a complete or a significant NK activity. Specific recognition of PSA-derived peptides in healthy individuals may occur by an adaptive CTL immune response, while such recognition in PC patients may additionally or alternatively be mediated by an innate NK immune response. In conclusion, our work indicates that the PSA-specific CD8+ T cells exist in both healthy individuals and PC patients, but they have impaired function in patients as they failed to release IFN-γ and to kill targets without involving NK activity.",
keywords = "Cytotoxic T lymphocytes, Dendritic cells, NK activity, Prostate cancer, Prostate-specific antigen",
author = "Eyad Elkord and Williams, {Paul E.} and Howard Kynaston and Rowbottom, {Anthony W.}",
year = "2005",
month = "10",
doi = "10.1093/intimm/dxh309",
language = "English",
volume = "17",
pages = "1315--1325",
journal = "International Immunology",
issn = "0953-8178",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer

AU - Elkord, Eyad

AU - Williams, Paul E.

AU - Kynaston, Howard

AU - Rowbottom, Anthony W.

PY - 2005/10

Y1 - 2005/10

N2 - Induction of CTL responses specific for prostate-specific antigen (PSA)-derived peptides in healthy individuals and patients with prostate cancer (PC) was investigated. Eight PSA-derived peptides that have the potential to bind HLA-A2 molecules were examined. Peripheral blood lymphocytes isolated from HLA-A2-positive volunteers were expanded using autologous mature, PSA-derived peptide-pulsed dendritic cells. The expansion of IFN-γ-secreting CD8+ T cells specific for three of the eight PSA-derived peptides (PSA-2108-117, PSA-4141-150 and PSA-6146-154) was detected in healthy individuals, but not in patients with PC. Using HLA-A2/peptide tetramers, the PSA-specific CD8+ T cells were detectable at low frequency both in healthy individuals and patients with PC. Using flow cytometric cytotoxicity assays, the expanded effectors from healthy individuals were able to kill the PSA-expressing epithelial cell line LNCaP and the peptide-pulsed T2 cells in a MHC class I-restricted manner without involving NK activity. However, such killing by effectors expanded from prostatectomized patients involved a complete or a significant NK activity. Specific recognition of PSA-derived peptides in healthy individuals may occur by an adaptive CTL immune response, while such recognition in PC patients may additionally or alternatively be mediated by an innate NK immune response. In conclusion, our work indicates that the PSA-specific CD8+ T cells exist in both healthy individuals and PC patients, but they have impaired function in patients as they failed to release IFN-γ and to kill targets without involving NK activity.

AB - Induction of CTL responses specific for prostate-specific antigen (PSA)-derived peptides in healthy individuals and patients with prostate cancer (PC) was investigated. Eight PSA-derived peptides that have the potential to bind HLA-A2 molecules were examined. Peripheral blood lymphocytes isolated from HLA-A2-positive volunteers were expanded using autologous mature, PSA-derived peptide-pulsed dendritic cells. The expansion of IFN-γ-secreting CD8+ T cells specific for three of the eight PSA-derived peptides (PSA-2108-117, PSA-4141-150 and PSA-6146-154) was detected in healthy individuals, but not in patients with PC. Using HLA-A2/peptide tetramers, the PSA-specific CD8+ T cells were detectable at low frequency both in healthy individuals and patients with PC. Using flow cytometric cytotoxicity assays, the expanded effectors from healthy individuals were able to kill the PSA-expressing epithelial cell line LNCaP and the peptide-pulsed T2 cells in a MHC class I-restricted manner without involving NK activity. However, such killing by effectors expanded from prostatectomized patients involved a complete or a significant NK activity. Specific recognition of PSA-derived peptides in healthy individuals may occur by an adaptive CTL immune response, while such recognition in PC patients may additionally or alternatively be mediated by an innate NK immune response. In conclusion, our work indicates that the PSA-specific CD8+ T cells exist in both healthy individuals and PC patients, but they have impaired function in patients as they failed to release IFN-γ and to kill targets without involving NK activity.

KW - Cytotoxic T lymphocytes

KW - Dendritic cells

KW - NK activity

KW - Prostate cancer

KW - Prostate-specific antigen

UR - http://www.scopus.com/inward/record.url?scp=27144517441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144517441&partnerID=8YFLogxK

U2 - 10.1093/intimm/dxh309

DO - 10.1093/intimm/dxh309

M3 - Article

C2 - 16141246

AN - SCOPUS:27144517441

VL - 17

SP - 1315

EP - 1325

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 10

ER -